[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.204.108.121. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
March 1971

Recovery of Tritiated Thymidine After Intradermal Injection

Author Affiliations

Boston

From the Department of Dermatology, Beth Israel Hospital, and Harvard Medical School, Boston.

Arch Dermatol. 1971;103(3):304-305. doi:10.1001/archderm.1971.04000150074010
Abstract

Intradermal injection of tritiated compounds is a commonly used technique in dermatologic investigation. This study demonstrates a rapid loss of tritiated precursors of nucleic acids following intracutaneous injection in mammals. Thirty minutes following injection, less than 8% of the injected dose remains at the local site. In clinical studies with intradermal injections of such tritiated compounds, the dose and number of injections must be minimized, and the same precautions must be exercised as would be if the compounds were injected systemically.

×